{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:17:05Z","timestamp":1773281825193,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1016\/s0002-9394(02)01827-5","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T07:34:16Z","timestamp":1041060856000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":246,"title":["A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma"],"prefix":"10.1016","volume":"135","author":[{"given":"Robert S.","family":"Noecker","sequence":"first","affiliation":[]},{"given":"Monte S.","family":"Dirks","sequence":"additional","affiliation":[]},{"given":"Neil T.","family":"Choplin","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Bernstein","sequence":"additional","affiliation":[]},{"given":"Amy L.","family":"Batoosingh","sequence":"additional","affiliation":[]},{"given":"Scott M.","family":"Whitcup","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0002-9394(02)01827-5_BIB1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The advanced glaucoma intervention study (AGIS) 7","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The ocular hypertension treatment study","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0161-6420(01)00584-X","article-title":"Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP","volume":"108","author":"Brandt","year":"2001","journal-title":"Ophthalmology"},{"issue":"Suppl 4","key":"10.1016\/S0002-9394(02)01827-5_BIB4","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1016\/S0039-6257(01)00219-3","article-title":"1 + 2. 6-Month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated IOP","volume":"45","author":"Sherwood","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB5","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","article-title":"A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group","volume":"103","author":"Watson","year":"1996","journal-title":"Ophthalmology"},{"issue":"Suppl 4","key":"10.1016\/S0002-9394(02)01827-5_BIB8","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1016\/S0039-6257(01)00212-0","article-title":"Efficacy and safety of bimatoprost in patients with elevated IOP","volume":"45","author":"DuBiner","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02850299","article-title":"Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. The Bimatoprost Study Group 3","volume":"18","author":"Gandolfi","year":"2001","journal-title":"Adv Ther"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10543409508835115","article-title":"A useful testing strategy in phase III trials","volume":"5","author":"Morikawa","year":"1995","journal-title":"J Biopharm Stat"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB11","series-title":"Statistical methods for rates and proportions","year":"1981"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB12","series-title":"Nonparametrics. Statistical methods based on ranks","year":"1975"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0161-6420(00)00021-X","article-title":"Target pressure? Glaucomatologists\u2019 holey grail","volume":"107","author":"Singh","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9394(14)76896-5","article-title":"Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma","volume":"111","author":"Mao","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(01)01337-X","article-title":"A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension","volume":"133","author":"Nordmann","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0149-2918(00)89008-6","article-title":"Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma","volume":"22","author":"Simmons","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/S0002-9394(02)01827-5_BIB17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/bjo.79.1.12","article-title":"Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol","volume":"79","author":"Alm","year":"1995","journal-title":"Br J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402018275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402018275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:30:31Z","timestamp":1757593831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939402018275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0002939402018275"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9394(02)01827-5","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9394(02)01827-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Science Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}